In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis.

This study was conducted to determine species differences in covalent binding of the reactive metabolites of ethylbenzene (EB) formed in the liver and lung microsomes of mouse, rat and human in the presence of NADPH. These data further the understanding of the mechanism by which EB causes mouse specific lung toxicity and a follow-up to our earlier report of the selective elevation, although minor, of the ring-oxidized reactive metabolites in mouse lung microsomes (Saghir et al., 2009). Binding assays were also conducted with or without 5-phenyl-1-pentyne (5P1P), an inhibitor of CYP 2F2, and diethyldithiocarbamate (DDTC), an inhibitor of CYP 2E1 to evaluate their role in the formation of the related reactive metabolites. Liver and lung microsomes were incubated with (14)C-EB (0.22 mM) in the presence of 1mM NADPH under physiological conditions for 60 min. In lung microsomes, binding activity was in the order of mouse (812.4+/-102.2 pmol/mg protein)>>rat (57.0+/-3.2 pmol/mg protein). Human lung microsomes had little binding activity (15.7+/-1.4 pmol/mg protein), which was comparable to the no-NADPH control (9.9-16.7 pmol/mg protein). In liver microsomes, mouse had the highest activity (469.0+/-38.5 pmol/mg protein) followed by rat (148.3+/-14.7 pmol/mg protein) and human (89.8+/-3.0 pmol/mg protein). Presence of 5P1P or DDTC decreased binding across species and tissues. However, much higher inhibition was observed in mouse (86% [DDTC] and 89% [5P1P]) than rat (56% [DDTC] and 59% [5P1P]) lung microsomes. DDTC showed approximately 2-fold higher inhibition of binding in mouse and human liver microsomes than 5P1P (mouse=85% vs. 40%; human=59% vs. 36%). Inhibition in binding by DDTC was much higher (10-fold) than 5P1P (72% vs. 7%) in rat liver microsomes. These results show species, tissue and enzyme differences in the formation of reactive metabolites of EB. In rat and mouse lung microsomes, both CYP2E1 and CYP2F2 appear to contribute in the formation of reactive metabolites of EB. In contrast, CYP2E1 appears to be the primary CYP isozyme responsible for the reactive metabolites of EB in the liver.

[1]  Keith A. Johnson,et al.  Two generation reproduction study of styrene by inhalation in Crl-CD rats. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.

[2]  B. Conti,et al.  Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: current results and ongoing research. , 1985, American journal of industrial medicine.

[3]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[4]  A. Malkinson,et al.  Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice. , 1991, Experimental lung research.

[5]  T. Guenthner,et al.  Cytochrome P-450-dependent metabolism of xenobiotics in human lung. , 1991, Journal of biochemical toxicology.

[6]  M. Gross,et al.  Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. , 2002, Carcinogenesis.

[7]  T. Baillie,et al.  Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.

[8]  G. Douglas,et al.  Mutagenicity of constituents identified in pulp and paper mill effluents using the Salmonella/mammalian-microsome assay. , 1980, Mutation research.

[9]  Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines. , 1993, Carcinogenesis.

[10]  T. Baillie,et al.  Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology. , 2006, Chemical research in toxicology.

[11]  S. Fustinoni,et al.  Biological and environmental monitoring of exposure to airborne benzene and other aromatic hydrocarbons in Milan traffic wardens. , 1995, Toxicology letters.

[12]  T. Devereux,et al.  Xenobiotic metabolism by isolated pulmonary cells. , 1989, Pharmacology & therapeutics.

[13]  E. Cavalieri,et al.  Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease. , 2010, Free radical biology & medicine.

[14]  C. Jefcoate,et al.  Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450. , 1987, Cancer research.

[15]  Y. Hiraku,et al.  Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage. , 2004, Chemico-biological interactions.

[16]  G. Carlson,et al.  METABOLISM OF THE STYRENE METABOLITE 4-VINYLPHENOL BY RAT AND MOUSE LIVER AND LUNG , 2001, Journal of toxicology and environmental health. Part A.

[17]  J. Bolton,et al.  Synthesis and reactivity of the catechol metabolites from the equine estrogen, 8,9-dehydroestrone. , 2001, Chemical research in toxicology.

[18]  H. Norppa,et al.  Induction of sister-chromatid exchanges by styrene analogues in cultured human lymphocytes. , 1983, Mutation research.

[19]  S. Kennedy,et al.  Simultaneous measurement of cytochrome P4501A catalytic activity and total protein concentration with a fluorescence plate reader. , 1994, Analytical biochemistry.

[20]  G. B. Smith,et al.  Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  J. Foster,et al.  The role of cytochromes P-450 in styrene induced pulmonary toxicity and carcinogenicity. , 2001, Toxicology.

[22]  K. Krishnan,et al.  Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice. , 2006, Toxicology and applied pharmacology.

[23]  Engström Km.  Metabolism of inhaled ethylbenzene in rats. , 1984 .

[24]  L. Fishbein.  An overview of environmental and toxicological aspects of aromatic hydrocarbons. IV. Ethylbenzene. , 1985, The Science of the total environment.

[25]  L. Pohl,et al.  Covalent binding of electrophilic metabolites to macromolecules. , 1981, Methods in enzymology.

[26]  G. Smoorenburg,et al.  Differential susceptibility of rats and guinea pigs to the ototoxic effects of ethyl benzene. , 2002, Neurotoxicology and teratology.

[27]  A. DeCaprio.  The toxicology of hydroquinone--relevance to occupational and environmental exposure. , 1999, Critical reviews in toxicology.

[28]  T. Kawai,et al.  Comparative evaluation of urinalysis and blood analysis as means of detecting exposure to organic solvents at low concentrations , 1992, International archives of occupational and environmental health.

[29]  M. Bartels,et al.  Mechanism of ethylbenzene-induced mouse-specific lung tumor: metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  E. Zeiger,et al.  Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals , 1992, Environmental and molecular mutagenesis.

[31]  D. Mcgregor,et al.  Responses of the L5178Y tk+/tk− mouse lymphoma cell forward mutation assay ii: 18 coded chemicals , 1988, Environmental and molecular mutagenesis.

[32]  D. H. Hutson,et al.  Genetic toxicology testing of 41 industrial chemicals. , 1985, Mutation research.

[33]  J. Angerer,et al.  Determination of low level exposure to volatile aromatic hydrocarbons and genotoxic effects in workers at a styrene plant. , 1995, Occupational and environmental medicine.